Brolucizumab May Offer Anti-VEGF Nonresponders An Option
Researchers report on early experiences of European patients who switched to brolucizumab therapy after undergoing other anti-VEGF injections.
Anti-VEGF Drugs
Study: In Patients With Multiple Diabetic Eye Diseases, Inject Before Laser
A study shows panretinal photocoagulation timing in diabetic retinopathy with diabetic macular edema affects the number of required injections, but yields similar outcomes.
Combination Treatment Effective, Safe in Persistent Diabetic Macular Edema
The study suggests patients treated with both agents demonstrated long-lasting visual efficacy.
Retinal Exudates Result in Worse Long-Term Visual Acuity
Researchers support use of anti-VEGF therapy in eyes that have inferior posterior staphyloma with choroidal neovascularization.
Patient Age May Impact Retinal Vein Occlusion Rehabilitation, Visual Outcomes
A study shows younger patients have more rapid, better reconstruction of retinal perfusion.
Key Takeaways From SECO 2021
We have published our coverage of The Southeastern Educational Congress of Optometry (SECO) 2021 Meeting, which you can find on the SECO 2021 meeting page. The meeting was captivating, and covered a range of topics relevant to both optometrists and ophthalmologists. The presenters offered insights on neuro-ophthalmology, pediatric eye disease, emerging technology, new treatment approaches, and viral…
Preventive Aflibercept Injections May Stave Off Diabetic Eye Disease Progression
A study shows periodic dosing can affect the development of proliferative diabetic retinopathy and diabetic macular edema.
Disease Recurrence Common, But Unpredictable in Neovascular AMD
Evidence of recurrent nAMD was seen in more than half of the study’s participants.
No Ocular Abnormalities in Newborns Exposed to COVID-19 In Utero
Although congenital viral infections can frequently lead to ocular abnormalities, research suggests this is not the case for COVID-19.
Wet Age-Related Macular Degeneration Linked to Hypertension
Wet AMD patients with hypertension were more likely to receive anti-VEGF drug intravitreal injections than those without hypertension, the study shows.
- Loading...
Loading...
Next post in Retina & Vitreous
Loading... 
Loading...